2011 Annual Meeting | Advanced Palliative Care and Symptom Management of ALS, Alzheimer's Disease, Parkinson's Disease, and Brain Tumors

Date Sunday 04/10/11

Time 11:00 AM - 02:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Extended Seminar

Director(s) Vanessa K. Hinson, MD, PhD, FAAN

Topic(s) Ethics/Professionalism

Learning Objectives Participants should be able to describe and discuss principles of palliative care in neurology, core principles for decision-making at the end of life, and evidence-based palliative care symptom management strategies for patients with ALS, brain tumors, Alzheimer's disease, and Parkinson's disease.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
11:00 AM - 11:10 AM		Introduction to Palliative Care in Neurology Vanessa K. Hinson, MD, PhD, FAAN
11:10 AM - 11:45 AM		Symptom Management and Palliative Care of Brain Tumor Patients Vinaykumar Puduvalli, MD
11:45 AM - 11:50 AM		Questions and Answers Vinaykumar Puduvalli, MD
11:50 AM - 12:25 PM		Treating Progressive Neurodegenerative Disease: Lessons from ALS-Crossing the Lines Between Treating Symptoms and Treating Diseases Jeffrey Rosenfeld, MD, PhD, FAAN
12:25 PM - 12:30 PM		Questions and Answers Jeffrey Rosenfeld, MD, PhD, FAAN
12:30 PM - 12:40 PM		Break
12:40 PM - 01:15 PM		Moderate to Advanced Stages of Dementia: Palliative Care Questions and Some Answers Tiffany W. Chow, MD, FAAN
01:15 PM - 01:20 PM		Questions and Answers Tiffany W. Chow, MD, FAAN
01:20 PM - 01:55 PM		Parkinson's Disease: Effective Palliation of Motor and Non-Motor Symptoms Vanessa K. Hinson, MD, PhD, FAAN
01:55 PM - 02:00 PM		Questions and Answers Vanessa K. Hinson, MD, PhD, FAAN

Faculty Disclosures
Vanessa K. Hinson, MD, PhD, FAAN	The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Jeffrey Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Vinaykumar Puduvalli, MD	Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Tiffany W. Chow, MD, FAAN	Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.

��ɫ��

��ɫ��